Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate


Showing posts with label V-pak. Show all posts
Showing posts with label V-pak. Show all posts

Thursday, January 29, 2015

Expensive Hepatitis C Cure ─ Georgia Decides Who Gets It, Who Doesn't

There’s a new drug on the market that’s up to 99 percent effective at curing hepatitis C, an often deadly liver virus. The drug is known as “V-pak.”

Some Georgians will get it.

But thousands of HIV-positive Georgians, who also have hepatitis C, won't.

The reason? Cost.


Read more and listen to the podcast here....

Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)